| Formulary Chapter 3: Respiratory system - Full Chapter
|
| 03.01.05 |
Peak flow meters, inhaler devices and nebulisers |
|
|
| 03.01.05 |
Peak flow meters |
|
|
| 03.01.05 |
Drug delivery devices |
|
|
| 03.01.05 |
Nebuliser Diluent |
|
|
Low range peak flow meter
 
|
Non Formulary
|
BRANDS
- Medi Peak Flow Meter
- Mini-wright Peak Flow
- Nspire Pocket Peak Peak
|
Standard range peak flow meter
|
Non Formulary
|
BRANDS
- Airzone Peak Flow Meter
- Fyne Dynamics Pinnacle Peak Flow Meter
- Medi Peak Flow Meter
- Micropeak Peak Flow Meter
- Mini-wright Peak Flow Meter
- Nspire Piko-1 Peak Flow Meter
- Nspire Pocket Peak Peak Flow Meter
- Philips Respironics Personalbest Peak Flow Meter
- Vitalograph Child Peak Flow Meter
- Vitalograph Mypef Peak Flow Meter
- Vitalograph Peak Flow Meter
|
Key |
 |
Restricted Drug |
 |
Unlicensed |
|
|
Link to adult BNF
|
|
|
Link to children's BNF
|
|
|
Link to SPCs
|
|
Cytotoxic Drug |
|
Controlled Drug |
|
|
High Cost Medicine |
|
Cancer Drugs Fund |
|
NHS England |
|
Homecare |
|
ICB |
|
Low carbon footprint |
|
Medium carbon footprint |
|
High carbon footprint |
|
| Status |
Description |
|
Medicines which are suitable for initiation and maintenance prescribing by primary and secondary care clinicians. These medicines should be initiated and prescribed within their licensed indications |
|
Amber Specialist Initiation: Initiation and maintenance of prescribing by Specialists and transfer to Primary Care prescribing when appropriate. This may be supported by a RICaD, annotated within the formulary entry. |
|
Amber Shared Care: Initiation and maintenance of prescribing by Specialists and transfer to Primary Care prescribing, in accordance with an ESCA, annotated within the formulary entry. |
|
Amber Specialist Recommendation: Initiation and maintenance of prescribing in Primary Care following recommendation from a specialist. |
|
Medicines for initiation and maintenance prescribing by Specialists (hospital or GPs with Special Interest) only |
|
Positive NICE TA and /or awaiting local clarification on place in therapy; Please contact your Medicines Optimisation team for more information. |
|
Non-formulary Medicines which APC/Trust DTC has actively reviewed and do not recommend for use. |
|
Check Notes as varies across the area |
|
|
